即时定量PCR法和等位基因特异性寡核苷酸PCR法检测肺腺癌EGFR基因第21号外显子L858R突变的对比性研究
被引量:2
摘要
自从Lynch等和Paez等发现肺癌细胞中上皮生长因子受体(EGFR)酪氨酸激酶编码区基因突变以来,研究证明具有EGFR基因第19号外显子(del746-A750)缺失突变或第21号外显子L858R错义突变的肺癌患者使用酪氨酸激酶抑制剂吉非替尼进行分子靶向治疗的有效率高达80%以上,而对于缺乏EGFR突变的患者采用上述治疗则基本无效。
出处
《中华病理学杂志》
CAS
CSCD
北大核心
2011年第5期338-340,共3页
Chinese Journal of Pathology
参考文献14
-
1Lynch TJ,Bell DW,Sordella R,et al.Activating mutations in the epidermal growth factor receptor underlying responsiveness of nonsmall-cell lung cancer to gefitinib.N Engl J Med,2004,350(21):2129-2139.
-
2Psez JG,Janne PA,Lee JC,et al.EGFR mutations in lung caucer:correlation with clinical response to gefitinib therapy.Science,2004,304(5676):1497-1500.
-
3Rafael R,Teresa M,Cristina Q,et al.Secening for epidermal growth factor receptor mutations in lung cancer.N Engl J Med,2009,361(10):958-967.
-
4Shigematsu H,Gazdar AF.Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers.Int J Cancer,2006,118(2):257-262.
-
5Ohnishi H,Ohtsuka K,Ooide A,et al.A simple and sensitive method for detecting major mutations within the tyrosine kinase domain of the epidermal growth factor receptor gene in non-smallcell lung carcinoma.Diagn Mol Pathol,2006,15(2):101-108.
-
6Tanaka T,Nagai Y,Miyazawa H.et al.Reliability of the peptide nucleic acid-locked nucleic acid polymersse chain reaction clampbased test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small-cell lung cancers.Cancer Sci,2007,98(2):246-252.
-
7Endo K,Konishi A,Sasaki H,et al.Epidermal growth factor receptor gene mumfion in non-small cell lung cancer using highly semitve and fast TaqMan PCR assay.Lung Cancer,2005,50(3):375-384.
-
8Miho U,Kamyuki M,Chiaki T,et al.Simple polymerase chain reaction for the detection of mutations and deletions in the epidermal growth factor receptor gene:applications of this method for the diagnosis of non-small-cell lung cancer.Clinica Chimica Acta,2009,40l(1-2):68-72.
-
9Tong KF,Chart KC,Tony SK,et al.Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small-cell lung cancer patients.CIin Cancer Res,2009,15(6):2076-2084.
-
10Pierre LP,Astrid L,Blons H,et al.Mutations and response to epidermal growth factor receptor inhibitors.Clin Cancer Res,2009,15(4):1133-1139.
同被引文献21
-
1Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med, 2008,358(11) : 1160-1174.
-
2Sharma SV, Bell DW, Settleman J, et al. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer, 2007,7 (3) : 169-181.
-
3Gazdar AF. Activating and resistance mutations of EGFR in non- small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors. Oncogene, 2009,28 Suppl 1: S24-31.
-
4Rosell R, Molina MA, Costa C, et al. Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations. Clin Cancer Res, 2011,17 ( 5 ) : 1160-1168.
-
5Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin- paclitaxel in puhnonary adenocarcinoma. N Engl J Med, 2009, 361 (10) :947-957.
-
6Zhang X, Chang A. Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer. J Med Genet, 2006,44 ( 3 ) : 166-172.
-
7Penzel R, Sets C, Chen Y, et al. EGFR mutation detection in NSCLC-assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC. Virchows Arch, 2011,458 ( 1 ) :95-98.
-
8Uhara M, Matsuda K, Taira C, et al. Simple polymerase chain reaction for the detection of mutations and deletions in the epidermal growth factor receptor gene: applications of this method for the diagnosis of non-small-cell lung cancer. Clin Chim Acta, 2009,401 (1-2) : 68-72.
-
9Pirker R, Herth FJ, Kerr KM, et al. Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol,2010 ,5 (10) : 1706-1713.
-
10Ohnishi H, Ohtsuka K, Ooide A, et al. A simple and sensitive method for detecting major mutations within the tyrosine kinase domain of the epidermal growth factor receptor gene in non-small-cell lung carcinoma. Diagn Mol Pathol, 2006,15(2) : 101-108.
引证文献2
-
1邓磊,唐源,林静,陆小军,薛建新,王立帅,周麟,邹艳,应斌武,李甘地,卢铀.等位基因特异性寡核苷酸和双环探针特异引物荧光聚合酶链反应检测非小细胞肺癌表皮生长因子受体基因突变[J].中华病理学杂志,2012,41(1):20-22.
-
2赵诤,李海军,陈效琴,任静,赵世财.晚期非小细胞肺癌患者TKI靶向治疗与肿瘤组织EGFR基因突变的关系[J].中国医药导报,2019,16(10):162-165. 被引量:12
二级引证文献12
-
1李梦远,华陈,罗建华,潘君素.EGFR-TKI治疗表皮生长因子受体野生型晚期肺腺癌1例并文献复习[J].临床与病理杂志,2019,39(12):2886-2889. 被引量:3
-
2郭杨,贾惠军,姚洁,董博,杨锋,刘芳,李晓伟,刘德玉.左肺下叶中分化腺癌1例误诊分析[J].中国医药导报,2020,17(18):181-184.
-
3杨燕君,张晓丽,董跃华,姜伟华,王贵刚,魏玉磊,周义,高永山.血清甲状腺转录因子1水平对表皮生长因子受体酪氨酸激酶抑制剂治疗肺腺癌效果的评估价值[J].中国医药,2020,15(9):1372-1376. 被引量:7
-
4孔维请.EGFR基因突变对非小细胞肺癌患者靶向治疗效果的影响[J].当代医药论丛,2021,19(8):61-63.
-
5蔡利娟.培美曲塞与多西他赛在晚期非小细胞肺癌靶向治疗失败后挽救化疗中的效果评价[J].中国卫生工程学,2021,20(3):496-497. 被引量:1
-
6陈美任.多种肿瘤相关自身抗体在非小细胞肺癌中的诊断效果分析[J].中国当代医药,2021,28(28):54-56.
-
7张颖,王淑玲,陈云峰,李涛.多种血清肿瘤标志物联合判断老年晚期肺腺癌EGFR突变的价值[J].中国医学创新,2021,18(28):126-129. 被引量:1
-
8石功亮,颜艳倩.表皮生长因子受体酪氨酸激酶抑制剂靶向治疗肺癌患者的临床效果及其对患者肺功能指标的影响[J].临床合理用药杂志,2022,15(3):1-4. 被引量:3
-
9吴宽,董小萍,俞华琴.免疫治疗对晚期非小细胞肺癌患者循环肿瘤细胞水平与免疫功能的影响[J].中外医学研究,2022,20(8):57-60. 被引量:1
-
10关月,张跃,时洪洋,李芬.非小细胞肺癌精准治疗疗效影响因素的研究进展[J].癌症进展,2023,21(5):468-472.
-
1叶明,周岱,周幽心,张世明,黄煜伦,徐峰.siRNA对人脑胶质瘤细胞Survivin基因表达的影响[J].中华神经外科杂志,2011,27(2):144-147. 被引量:5
-
2徐广敏.5-Aza-dC及TSA对人胃癌细胞株SGC-7901 Runx3基因甲基化和表达水平的影响解析[J].家庭心理医生,2015,11(5):555-555.
-
3薛志强,郑抗洪,黄晓峰,刘世信.遗传性非息肉病性大肠癌[J].中国中西医结合外科杂志,2001,7(4):248-249.
-
4石瑞芳.PTEN、p53与EGFR在乳腺癌中表达的临床病理意义及其相关性分析[J].中国继续医学教育,2017,9(3):50-51. 被引量:4
-
5季永胜,张中平,陈育健,高峰.C-erbB-2及EGFR在胃癌组织中的表达及其与胃癌侵袭转移的关系[J].胃肠病学和肝病学杂志,2008,17(12):1019-1022. 被引量:2
-
6张学敏,陈德蕙.MCF—7乳腺癌细胞上皮生长因子受体的免疫荧光和...[J].中华病理学杂志,1990,19(2):106-108.
-
7杨秀红,常鸿,刘正泉.促血管生成相关蛋白在乳腺肿瘤发展进程中的作用[J].河北医药,2016,38(5):763-766. 被引量:1
-
8梁宝权,侯顺玉,金蕴洁.细胞色素P450基因多态性与宫颈上皮内瘤变遗传易感性的关系[J].山东医药,2016,56(22):81-82.
-
9周磊,肖然,陈颖,张菁,卢仁泉,郭林.人附睾蛋白4基因表达下调对卵巢癌细胞生物学行为的影响[J].中华病理学杂志,2013,42(10):687-690. 被引量:5
-
10郑海燕,阮健,潘玲兰,刘见桥.溶酶体组织蛋白酶L对人卵巢癌SKOV3细胞迁移及侵袭的作用[J].肿瘤防治研究,2015,42(6):556-559. 被引量:2